Verus Pharmaceuticals: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
'''Verus Pharmaceuticals''' | == Verus Pharmaceuticals == | ||
[[File:Verus_pharmaceuticals.png|thumb|right|Logo of Verus Pharmaceuticals]] | |||
'''Verus Pharmaceuticals''' was a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of [[pediatric]] and [[allergy]]-related conditions. The company was based in [[San Diego, California]]. | |||
== History == | == History == | ||
Verus Pharmaceuticals was founded in | Verus Pharmaceuticals was founded with the aim of addressing unmet medical needs in the pediatric population, particularly in the areas of [[asthma]] and [[allergy]]. The company sought to develop innovative solutions that would improve the quality of life for children suffering from these conditions. | ||
== Products == | == Products == | ||
Verus Pharmaceuticals | Verus Pharmaceuticals developed several products aimed at treating pediatric asthma and allergy. One of their notable products was an [[epinephrine]] auto-injector designed for the emergency treatment of [[anaphylaxis]]. This product was intended to be user-friendly and specifically tailored for use in children. | ||
== Acquisition == | |||
In 2008, Verus Pharmaceuticals sold its pediatric asthma development programs to [[AstraZeneca]], a global biopharmaceutical company. This acquisition allowed AstraZeneca to expand its portfolio in the respiratory field and continue the development of Verus's innovative products. | |||
== Impact == | |||
The work of Verus Pharmaceuticals contributed to advancements in the treatment of pediatric asthma and allergy. By focusing on the specific needs of children, the company played a role in improving therapeutic options and outcomes for young patients. | |||
== Related pages == | |||
* [[Pharmaceutical industry]] | |||
* [[Pediatrics]] | |||
* [[Allergy]] | |||
* [[Asthma]] | |||
[[Category:Pharmaceutical companies | [[Category:Pharmaceutical companies]] | ||
[[Category:Companies based in San Diego]] | [[Category:Companies based in San Diego, California]] | ||
[[Category: | [[Category:Defunct companies of the United States]] | ||
Latest revision as of 06:47, 16 February 2025
Verus Pharmaceuticals[edit]
Verus Pharmaceuticals was a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of pediatric and allergy-related conditions. The company was based in San Diego, California.
History[edit]
Verus Pharmaceuticals was founded with the aim of addressing unmet medical needs in the pediatric population, particularly in the areas of asthma and allergy. The company sought to develop innovative solutions that would improve the quality of life for children suffering from these conditions.
Products[edit]
Verus Pharmaceuticals developed several products aimed at treating pediatric asthma and allergy. One of their notable products was an epinephrine auto-injector designed for the emergency treatment of anaphylaxis. This product was intended to be user-friendly and specifically tailored for use in children.
Acquisition[edit]
In 2008, Verus Pharmaceuticals sold its pediatric asthma development programs to AstraZeneca, a global biopharmaceutical company. This acquisition allowed AstraZeneca to expand its portfolio in the respiratory field and continue the development of Verus's innovative products.
Impact[edit]
The work of Verus Pharmaceuticals contributed to advancements in the treatment of pediatric asthma and allergy. By focusing on the specific needs of children, the company played a role in improving therapeutic options and outcomes for young patients.
